Dr Reddy's Laboratories reply to clarification sought by exchange

05 Apr 2022 Evaluate

Dr Reddy's Laboratories has informed that the Exchange had sought clarification with respect to news article appearing on https://economictimes.indiatimes.com dated March 31, 2022 titled ‘Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance’. Dr Reddys Laboratory’s response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1295.20 -23.70 (-1.80%)
27-Feb-2026 10:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1768.35
Dr. Reddys Lab 1295.20
Cipla 1342.40
Zydus Lifesciences 923.25
Lupin 2309.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×